Effects of Intracellular Calcium and Actin Cytoskeleton on TCR Mobility Measured by Fluorescence Recovery by Dushek, Omer et al.
Effects of Intracellular Calcium and Actin Cytoskeleton
on TCR Mobility Measured by Fluorescence Recovery
Omer Dushek
1., Sabina Mueller
2., Sebastien Soubies
2¤a, David Depoil
2¤b, Iris Caramalho
2¤c, Daniel
Coombs
1., Salvatore Valitutti
2.*
1Department of Mathematics and Institute of Applied Mathematics, University of British Columbia, Vancouver, British Columbia, Canada, 2INSERM, U563, Centre de
Physiopathologie de Toulouse Purpan, Section Dynamique mole ´culaire des interactions lymphocytaires, Toulouse, France
Abstract
Background: The activation of T lymphocytes by specific antigen is accompanied by the formation of a specialized signaling
region termed the immunological synapse, characterized by the clustering and segregation of surface molecules and, in
particular, by T cell receptor (TCR) clustering.
Methodology/Principal Findings: To better understand TCR motion during cellular activation, we used confocal
microscopy and photo-bleaching recovery techniques to investigate the lateral mobility of TCR on the surface of human T
lymphocytes under various pharmacological treatments. Using drugs that cause an increase in intracellular calcium, we
observed a decrease in TCR mobility that was dependent on a functional actin cytoskeleton. In parallel experiments
measurement of filamentous actin by FACS analysis showed that raising intracellular calcium also causes increased
polymerization of the actin cytoskeleton. These in vitro results were analyzed using a mathematical model that revealed
effective binding parameters between TCR and the actin cytoskeleton.
Conclusion/Significance: We propose, based on our results, that increase in intracellular calcium levels leads to actin
polymerization and increases TCR/cytoskeleton interactions that reduce the overall mobility of the TCR. In a physiological
setting, this may contribute to TCR re-positioning at the immunological synapse.
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Introduction
The activation of T lymphocytes by antigenic ligands displayed
on the surface of antigen presenting cells (APC) is the central event
in developing an adaptive immune response. During the T cell/
APC interaction, TCR bind to peptide-major-histocompatibility-
complex (pMHC) present on the surface of the APC [1]. T cells
are observed to respond sensitively and specifically to antigenic
stimulation [2,3].
Upon conjugation between T cells and APC, TCR and
accessory molecules move towards the T cell/APC contact site,
forming a signaling area at the interface that has been named the
immunological synapse (IS) [4,5]. TCR movement towards the IS
has been thoroughly documented and shown to reflect the
intensity of antigenic stimulation [6,7] but we do not have a
complete picture of how surface receptor signaling modulates
TCR motion.
TCR motion on live cells has been studied using fluorescence
recovery after photo-bleaching (FRAP, [8]) and fluorescence loss
in photo-bleaching (FLIP, [8]) techniques. In a primary study,
Sloan-Lancaster et al. showed that GFP-tagged CD25/f-chain
chimeras expressed on the surface of HeLa cells exhibit very low
mobility [8]. Following this observation, we employed a TCR b
chain-deficient Jurkat T cell line transfected with a GFP/fusion
TCR b-chain to measure lateral mobility of fully assembled TCR/
CD3 complexes using FRAP. We showed that TCR are mobile on
the surface of Jurkat T cells [9]. Using a different approach, M.
Krummel and colleagues also showed that TCR are mobile on the
surface of murine T cells and that they accelerate towards the IS
during antigen recognition [10]. More recently, it has been shown
that TCR dynamically form micrometer-scale clusters that move
in a directed fashion towards the center of the IS during antigen
recognition [11–13]. TCR recruitment to the center of the IS has
been associated with productive signaling [5,14] and with TCR
internalization [13,15].
TCR directed motion requires an energy-consuming mecha-
nism and a natural candidate for this mechanism is an interaction
between TCR and the cortical actin cytoskeleton (CAC). T cells
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with APC [13,16,17] and cortical actin has further been
implicated in the transport of IS components to the T cell/APC
contact site [18–20]. However, an explicit link between the actin
cytoskeleton and TCR dynamics has not been established at the
molecular level. In particular it is not clear how activation signals
triggered by TCR engagement might modulate TCR mobility via
CAC-dependent mechanisms.
Here, we report on efforts to characterize TCR mobility in
human T lymphocytes using fluorescence recovery techniques. We
stimulated T cells using ionomycin, a drug known to increase the
concentration of intracellular calcium ([Ca
2+]i). We show that
[Ca
2+]i increase markedly reduces TCR mobility on the T cell
surface via an actin cytoskeleton-dependent mechanism. We also
show that actin polymerization increases following [Ca
2+]i
increase, suggesting a direct link between calcium induced CAC
polymerization and constraints on TCR mobility on the T cell
surface.
Results
TCR mobility is similar in naı ¨ve and activated human T
cells
We initially focused on studying TCR mobility on unstimulated
T cells. We used three CD4
+ T cell populations: naı ¨ve T
lymphocytes freshly isolated from cord blood (CBTL); T cells from
a line obtained by cultivating for two weeks in vitro naı ¨ve T cells in
the presence of magnetic beads coated with anti-CD3 plus anti-
CD28 mAb (activated CBTL); freshly isolated T lymphocytes from
peripheral blood of adult healthy donors (PBL). We stained cells
from each population using anti-CD3 Fab antibodies labeled with
Cy5 [7,21] and performed FRAP experiments. We applied the
method described in Dushek at al. [22] to analyze FRAP recovery
curves and extract the mobility parameters of the TCR. Two
parameters were calculated: the diffusion coefficient (D, generally
expressed in mm
2/s) and the mobile fraction (Mf), indicating the
fraction of TCR that are mobile on the timescale of the
experiment. The results of this analysis are presented in Figure 1
and Table 1. TCR had a diffusion coefficient (D, expressed as
mean6SEM)) of 0.04860.008 mm
2/s in CBTL, 0.0356
0.006 mm
2/s in activated CBTL and 0.06160.008 mm
2/s in
PBL. The values of D were not found to be significantly different
(p.0.05). The mobile fraction (Mf) of TCR was very high in all
cell populations, supporting the notion that TCR are constitutively
mobile on living T cells (Table 1).
These results show that the basic parameters of TCR dynamics
on the surface of T cells are not significantly different in T cells at
different stages of activation, indicating that TCR mobility is not
involved in allowing activated T cells to be more responsive to
antigenic stimulation.
[Ca
2+]i increase affects TCR mobility by an actin
cytoskeleton dependent mechanism
We next investigated whether calcium signaling in T cells could
affect TCR mobility. To this end, T cells were loaded with the
calcium probe FLUO-4 (a dye that increases its light emission
when bound to Ca
2+) before staining with anti-CD3/Cy5 Fab
antibodies. This allowed us to detect signal transduction in parallel
with TCR dynamics [7,23]. We stimulated T cells with ionomycin
to mimic the [Ca
2+]i increase that follows productive TCR
engagement [24]. Our results show that [Ca
2+]i increase results in
a substantial decrease in TCR lateral diffusion in PBL, as
measured by a reduction of D (Fig. 2A and Table 1). Pre-
treatment of T cells with 10 mM cytochalasin D (a drug that
inhibits actin cytoskeleton function) abolished the effect of
ionomycin on TCR mobility (Fig. 2A). The values of D were
0.01760.002 mm
2/s in PBL treated with ionomycin, 0.0686
/>0.014 mm/s in PBL treated with cytochalasin D only and
0.04360.004 mm/s in PBL treated with both cytochalasin D and
ionomycin. Similar results were obtained when T cells were
treated with 50 nM latrunculin B instead of cytochalasin D ().
Interestingly, cytochalasin D/latrunculin B treatements did not
significantly affect basal lateral mobility of TCR indicating that
this process is not dependent on actin cytoskeleton function.
Ionomycin treatment, although affecting TCR lateral diffusion (D
values) did not affect the mobile fraction of TCR that was again
Figure 1. TCR mobility does not depend on the activation state of T cells. Mean FRAP recovery curves are shown for peripheral blood T
Lymphocytes (PBL, blue curve n=61), Cord Blood T Lymphocytes either freshly isolated (CBTL, green curve n=20) or activated in culture (activated
CBTL, red curve n=20). Data are from 2 (for CBTL) and 4 (for PBL) independent experiments.
doi:10.1371/journal.pone.0003913.g001
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activation of the calcium signaling pathway reduces TCR mobility
in T cells by an actin cytoskeleton-dependent mechanism. They
also show that [Ca] increase, although reducing the mobility of
individual TCR, does not reduce the number of mobile
molecules.<figure-acer number="
[Ca
2+]i increase induces polymerization of the actin
cytoskeleton
The above results suggested that, following [Ca
2+]i increase, the
actin cytoskeleton becomes a constraint for TCR mobility. To
define a link between [Ca
2+]i increase and actin cytoskeleton
function, we used FACS analysis to measure F-actin (polymerized
actin). PBL were either untreated or treated with increasing
concentrations of ionomycin or latrunculin B (as a control of actin
cytoskeleton de-polymerization) for 15 minutes at 37uC. Cells
were fixed, permeablized, and stained with Alexa-488 labelled
phalloidin to selectively tag F-actin. As shown in Figure 3,
treatment with latrunculin B decreased the amount of F-actin in T
cells in a dose-dependent fashion, supporting the notion that
FACS analysis is suitable for quantification of F-actin [25].
Treatment of T cells with ionomycin induced a moderate dose-
dependent increase in F-actin. These results indicate that [Ca
2+]i
increase augments the amount of F-actin in T cells and suggest
that the increase in actin polymerization could be responsible for
the observed effect of [Ca
2+]i increase on TCR mobility.
Modeling reveals effective TCR binding parameters to
the actin cytoskeleton
We have shown that the observed decrease in TCR mobility
following ionomycin treatment is mediated by the cortical actin
cytoskeleton. We can extend the pure diffusion model, used to
obtain the results in Table 1, to include binding interactions
between TCR and the actin cytoskeleton as follows,
Table 1. Diffusion coefficient and mobile fraction under various pharmacological treatments.
Condition n Diffusion Coefficient Mobile Fraction P-Value of Diffusion
(mm
2/s) (Mf) Relative to PBL*
PBL 61 0.06160.008 0.9660.04 1.00
CBTL 20 0.04860.008 1.0060.05 0.40
Activated CBTL 20 0.03560.006 1.0960.04 0.08
PBL+CytoD 20 0.06860.014 0.9360.05 0.66
PBL+LatB 10 0.08260.016 0.9560.06 0.34
PBL+Iono 37 0.01760.002 1.0060.04 0.0001
PBL+Iono+CytoD 25 0.04360.005 0.9260.04 0.17
PBL+Iono+LatB 10 0.04560.009 0.9960.05 0.45
*P-values were obtained by comparing diffusion coefficients from each experiment to the untreated PBL data using a two-sample T-test. Except for PBL+Iono no
significant differences in the diffusion coefficient were observed (P-values.0.05) No significant differences in the mobile fraction were observed (all P-values.0.05).
doi:10.1371/journal.pone.0003913.t001
Figure 2. TCR mobility is modulated by intracellular calcium via the actin cytoskeleton. A. Mean FRAP recovery curves are shown for
Peripheral blood T Lymphocytes (PBL, blue curve n=61), PBL treated with cytochalasin D (PBL+CytoD, green curve n=20), PBL treated with
ionomycin (PBL+iono, orange curve n=37), and PBL treated with ionomycin and cytochalasin D (PBL+Iono+CytoD, light blue curve n=25). B. Mean
FRAP recovery curves are shown for PBL (blue line, n=61) PBL treated with latrunculin B (PBL+LatB, pink curve n=10), PBL treated with ionomycin
(PBL+iono, orange curve n=37), and PBL treated with ionomycin and latrunculin B (PBL+Iono+LatB, red curve n=10).
doi:10.1371/journal.pone.0003913.g002
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where T is the concentration of diffusing TCR, C is the
concentration of TCR bound to the cytoskeleton, D is the
diffusion coefficient of TCR, koff is the unbinding rate, and kon is the
effective binding rate. The effective binding rate is kon=k ¯onS, where
k ¯on is the intrinsic binding rate of TCR directly to the cytoskeleton
or binding through a putative mediator that links TCR to the
cytoskeleton. S is the concentration of binding sites available to
diffusing TCR which are assumed to be homogenously distributed.
This binding plus diffusion model has been previously used in
FRAP analysis to extract binding parameters [26].
I nT a b l e2w es u m m a r i z et h er e s u l t so ff i t t i n gt h ep u r e
diffusion model and the binding plus diffusion model described
above to the PBL data and the PBL+ionomycin data. When
fitting the binding model the only free parameters are kon and koff
and we set D=0.0609 mm
2/s, the free diffusion coefficient. The
fitting procedure we used is described in Dushek et al [22]. We
find that both the pure diffusion and binding models accurately
fit both data sets (Figure 4). Using a statistical test to compare the
explanatory power of each model (Akaike’s Information
Criterion, AIC) we find that both models explain the PBL data
equally well. However, we find that the binding model has
significant additional power in explaining the PBL+ionomycin
data (compare the probabilities in Table 2). This suggests that
TCR binding is quite possibly responsible for the slow FRAP
recovery after ionomycin treatment as opposed to explanations
involving a smaller mobile fraction or a change in the underlying
TCR diffusivity. In this case, the binding model reveals rapid
binding kinetics between the TCR and the putative cytoskeletal
binding partner with kon=0.22s
21 and koff=0.05s
21.P u t
another way, in the experiments with PBL+ionomycin, a TCR
might be expected to bind the cytoskeleton on average every 5 s
a n du n b i n da f t e r2 0s .
Discussion
In the present work we have shown, in agreement with previous
studies [9,10], that TCR are constitutively mobile on the surface of
T cells. This lateral mobility (with a diffusion coefficient in the
region of 0.05–0.1 mm
2/s) is in principle sufficient to allow
individual TCR to patrol the entire T cell surface within about
30 minutes. The diffusivity of TCR is similar in T cells at different
stages of activation, indicating that this parameter is not involved
in allowing activated T cells to be more responsive to antigenic
stimulation.
Fast lateral mobility and rapid cell surface patrolling by TCR
may be instrumental in resting conditions to allow T cells to
rapidly sense antigenic stimuli. However it seems likely that, upon
antigenic stimulation, regulated TCR motion would be needed to
Figure 3. [Ca
2+]i increase induces actin polymerization in PBL. PBL were treated for 15 minutes with latrunculin B (50 nM, 100 nM or 500 nM)
or with ionomycin (0.5 mg/ml, 1 mg/ml, 2.5 mg/ml). F-actin cellular content was measured by FACS analysis. Data are from one representative
experiment out of three. In parallel experiments the vehicle of the drugs (DMSO) did not affect actin polymerization.
doi:10.1371/journal.pone.0003913.g003
Figure 4. Fitting the diffusion and binding model to FRAP
recovery curves. We show the fit of the pure diffusion model (red)
and the binding+diffusion model (black) to the PBL data and to the
ionomycin-treated PBL. Both models provide a good fit to the recovery
curves but a statistical test reveals that the binding model is
significantly better at explaining the FRAP recovery when the PBL are
treated with ionomycin (Table 2).
doi:10.1371/journal.pone.0003913.g004
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[Ca
2+]i increase (a central and early signal in T cell activation)
induces a significant decrease of TCR mobility. Our results also
show that this reduction in TCR mobility requires a functional
actin cytoskeleton. This suggests that following [Ca
2+]i increase,
TCR become associated with actin cytoskeleton or with actin
binding proteins. Fitting a model for TCR diffusion and binding to
an immobile partner to our data suggests that this may indeed be
the case.
Our observations, by showing that TCR may be bound or
trapped by F-actin, raise the question of how they could move
towards the IS. It is well established that F-actin is enriched at the
IS [27]. Moreover, work from M.M. Davis and colleagues showed
that cortical F-actin moves towards the T cell/APC contact site in
antigens stimulated T cells [18]. Our present work points towards
an important role of actin cytoskeleton in control of TCR motion
although we did not focus in this study on TCR mobility during T
cell/APC cognate interaction.
We also showed that pharamcological [Ca
2+]i increase results in
a increased level of F-actin in T cells. The concentration of
ionomycin at which a clear shift in F-actin cellular content was
observed was 2.5 mg/ml. In the FRAP experiments, 0.5 mg/ml
ionomycin (a concentration previously used to activate T cells,
[16]) was sufficient to induce a reduction of TCR mobility. The
reason for this discrepancy is presently elusive. It is possible that
the effect on TCR mobility precedes significant actin polymeri-
zation. Alternatively, differences in sensitivity between the two
experimental methods could be the reason for the observed
discrepancy. This result suggests that upon initial conjugation of a
T cell with a cognate APC the productive and localized
engagement of a small number of TCR may lead rapidly via
[Ca
2+]i increase and actin polymerization to global control of
TCR motion.
Mathematical models of immune synapse formation commonly
include TCR transport towards the center of the immune synapse,
driven by the actin cytoskeleton [14,28–31]. Important parameters
in these models are effective reaction rates between TCR and the
actin cytoskeleton, which to our knowledge have not been
previously reported. For example, in the study of Burroughs et
al., it was assumed that the effective on- and off-rates were
identical and equal to 0.1 s
21. It would be interesting to
investigate the effects of a larger on-rate and smaller off-rate, as
reported in the present work, on the results of this and other
models.
Several lines of evidence established a link between CAC
polymerization and TCR signaling [32]. Treatment of T cells with
drugs affecting actin cytoskeleton such as cytochalasin D, aborts
antigen induced [Ca
2+]i increase indicating that actin polymeri-
zation is required to sustain signaling in T cells [16]. Moreover,
deficiency or mutation in several molecules regulating the actin
cytoskeleton such as Vav-1, Cdc42 and Wiskott-Aldrich syndrome
protein (WASP) affect IS formation [33]. Some of these proteins
such Nck and WASP are recruited to the TCR signaling area
together with polymerized actin [34].
Interestingly, while actin cytoskeleton polymerization is usually
considered to be required for the activation of calcium pathway
[16,32], here an original reverse mechanism is proposed: [Ca
2+]i
increase is shown to enhance actin cytoskeleton polymerization
and in turn modulate TCR mobility.
We speculate that the binding or trapping of TCR by the actin
cytoskeleton network could also be instrumental in favoring the
assembly of the TCR associated signaling cascade. The notion that
TCR move very rapidly is difficult to reconcile with the necessity
of assembling complexes of adaptor molecules and signaling
components at the IS. The observation that TCR mobility is
affected by global [Ca
2+]i increase is compatible with the
formation of localized signaling scaffolds favoring complex
molecular interactions. This hypothesis is in agreement with
reported data by M. Dustin and colleagues showing that a
functional actin cytoskeleton is required to allow TCR micro-
clusters to signal and that high concentration of polymerized actin
is confined to TCR clusters [13]. It is tempting to speculate that
global [Ca
2+]i increase induced by the engagement of a few TCR
at the T cell/APC contact site (via polimerization of CAC) might
lead to the rapid formation of a much greater number of TCR
clusters in the nascent IS. If so, this would equip T cells with pre-
formed signaling units ideal for sensitive detection of a limited
number of antigenic ligands.
Our work outlines a previously unexpected link between the
calcium pathway, the actin cytoskeleton and TCR mobility.
Although we have not examined the detailed mechanisms of
this triangular interaction our results highlight the ability of
TCR populations to control their own mobility via calcium
signaling.
Materials and Methods
Cell isolation and culture
Purification of CD4
+ human PBL: T cells were isolated from
the whole blood of healthy volunteer donors (Centre de
Transfusion Sanguine, CHU Purpan, Toulouse) as described
[35]. Briefly, PBMC were purified from blood by centrifugation
through Ficoll-Hypaque (Pharmacia Biotech, Sweden). CD4
+ T
lymphocytes were purified using RosetteSep Kit (StemCell
Technologies, Vancouver, Canada). Cell purity was assessed by
FACS analysis (Facscan, Becton Dickinson) using FITC-labelled
anti-CD4 mAb (clone RPA-T4, BD Pharmingen). CD4
+
fractions were routinely ,90% pure. Before use, purified T
cells were cultured in complete RPMI 1640 (Gibco, Paisley,
Scotland) containing 5% human serum. In parallel experiments,
umbilical Cord Blood T Lymphocytes from healthy volunteer
donors (CBTL) were purified from whole cord blood (kindly
Table 2. Model fitting to FRAP recovery curves.
PBL PBL+Iono
SSR AIC DAIC Prob. SSR AIC DAIC Prob.
Pure Diffusion Model 0.0449 2680.06 0.799 0.40 0.0281 2722.27 38.71 0.00
Diffusion+Binding Model 0.0445 2680.86 0.000 0.60 0.0183 2760.97 0.00 1.00
SSR – Sum of squared residuals, AIC – Akaike’s Information Criterion, Prob – Probability that the model is the better descriptor of the FRAP recovery curve based on AIC.
doi:10.1371/journal.pone.0003913.t002
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Viguier, CHU Purpan, Toulouse) as above described. In some
cases CBTL were cultured and expanded for 14 days in RPMI
1640, 5% human serum, IL-2 (150 IU/ml) using Dynabeads
CD3/CD28 T Cell Expander (Dynalbiotech, Oslo, Norway).
Bead: cell ratio was 1:1.
Fluorescence Recovery After Photobleaching
Anti-CD3e mAbs (TR66, IgG1, [36] were digested by using the
IgG1 Fab and F(ab)’2 kit (Pierce biotechnologyTM, Rockford).
Fab fragments (5 mg/ml in 0.1 M Sodium carbonate, pH=9.3)
were labelled with Cy5 Monoreactive dye pack (Amersham
BioscienceTM, Piscataway). The labelled Fab fragments were
separated from non-conjugated dye by gel chromatography by the
use of Nap-10 Columns (Amersham Bioscience). This step was
followed by an overnight dialysis in 16 PBS by using a Lyser
Dialysis cassettes (Pierce biotechnology) [7].
PBMC derived CD4
+ T cells were washed and re-suspended in
RPMI,5%FCS,10 mMHepes.Cellswereloadedwith 2 mMFl u o4
AM (Molecular Probes, Leiden, The Netherlands) for 30 minutes at
37uC. After washing, cells were stained with 30 mg/ml CD3/Cy5
Fab in RPMI, 1% FCS at 4uC for 30 minutes. Cells were washed
and kept in ice until used for FRAP experiments. FRAP was
performed in Lab-Tek chambers (Nalgene Nunc, Rochester, NY) in
pre-warmed 5% FCS/10 mM HEPES at 37uC, 5% CO2 on a
confocal microscope (LSM 510; Carl Zeiss, Jena, Germany) using a
Plan-Apochromate 636 objective and the 633 nm laser. A
rectangular region (2 mm61.4 mm) was defined on the surface of
T cells. This region was irradiated using the 633 nm, 543 nm and
488 nm lasers with 100% intensity for 3 s. The aperture of the
pinhole was adjusted to obtain optical slices of 2 mm depth. Before
and afterbleaching,the wholefield wasvisualized byirradiating with
488 nm laser with 4% intensity and 633 nm laser with 17%
intensity. Images were taken at 1 second intervals.
In some experiments, cells were treated either with ionomycin
(0.5 mg/ml) at the time of the time-lapse recording. In some
experiments cells were treated with cytochalasin D (10 mM) or
latrunculin B (50 nM) before the beginning of the assay.
Fitting procedures
We used the method for FRAP measurements of surface
diffusion described in [37]. Briefly, a small region of the cell
membrane was bleached and the fluorescence recovery curve was
fit using a two-dimensional recovery equation to estimate the TCR
diffusion constant and the mobile fraction of TCR. The Matlab
function lsqcurvefit was used for fitting.
We also fit a simple exponential to every FRAP experiment.
Using the time-constant of the recovery as an indicator of TCR
mobility gave the same conclusions as using the diffusion
coefficient (analysis not shown).
Quantification of F-actin by phalloidin staining and flow
cytometry
A method described by Downey et al [38] was used with some
modifications [25]. Briefly, after incubation at 37uC with different
draugs PBL were fixed with 3% PFA, permeabilized with 0.1%
saponin and stained with 160 nM Alexa 488-labelled phalloidin.
Cells were analyzed on a FACSCalibur (Becton Dickinson).
Gating was done to exclude by forward and side scatter criteria
cell debris and cell clumps. In some samples T cells were treated
with 0.5–2.5 mg/mL ionomycin or with 50 to 500 nM latrunculin
B for 15 minutes at 37uC, before fixation.
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